Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis
因维多珠单抗或皮下注射英夫利昔单抗维持治疗1年后疗效不佳而导致炎症性肠病患者停药率：系统文献综述和荟萃分析
期刊:
影响因子:
doi:10.1177/17562848251383767
Ferrante, Marc; Peyrin-Biroulet, Laurent; Arkkila, Perttu; Armuzzi, Alessandro; Colombel, Jean-Frédéric; Danese, Silvio; Faggiani, Roberto; Guardiola, Jordi; Hanauer, Stephen B; Jahnsen, Jorgen; Reinisch, Walter; Roblin, Xavier; Smith, Philip J; Sang Kwon, Taek; Kim, Seungmin; Nam, Kyoungwan; Atreya, Raja
